Navigation Links
KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
Date:9/9/2009

ctual or potential competitors or to the Company's ability to market generic products due to brand company patents and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company or its subsidiaries, including without limitation the litigation and claims referred to in Note 16 of the Notes to the Consolidated Financial Statements in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 and under the heading "Certain Other Matters" in the Company's Form 8-K filed with the SEC on April 30, 2009; (16) the possibility that the Company's current estimates of the financial effect of certain announced product recalls could prove to be incorrect; (17) whether any product recalls or product introductions result in litigation, agency action or material damages; (18) the possibility that the findings of the Audit Committee inquiry referenced in the Company's Form 10-Q for the quarter ended June 30, 2008, Form 12b-25 filed with the SEC on November 13, 2008, Form 12b-25 filed with the SEC on February 2, 2009, Form 12b-25 filed with the SEC on June 6, 2009, Form 8-K filed with the SEC on June 23, 2009, as well as certain other of the Company's SEC filings, could have a material impact on the Company's financial results; (19) the satisfaction or waiver of the other closing conditions in the previously disclosed Gestiva(TM) acquisition agreement; (20) the possibility that the auction rate securities held by the Company may not return to liquidity at their face value; (21) the consent decree between the Company and the FDA and the Company's suspension of the production and shipment of substantially all of the products that the Company manufactures and the related nationwide recall affecting substantially all of the products that the Company manufactures, as well as the expected material adverse effect on the Company's revenue, assets and liquidity and capital re
'/>"/>
SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
2. Isis Pharmaceuticals to Present at Morgan Stanleys Global Healthcare Unplugged Conference
3. FDA pharmaceutical import alert
4. KV Pharmaceutical Appoints Interim Chief Financial Officer
5. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
6. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
9. Steven Holtzman Joins Satori Pharmaceuticals Board of Directors
10. Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
11. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Francisco, CA (PRWEB) November 26, 2014 Gone ... hanker after cheap deals on Black Friday, which signifies the ... to clicking items into their shopping carts in the comfort ... crowds. , This Friday is going to be ... in a day, with an estimated $2.48 billion in revenue ...
(Date:11/26/2014)... Loffler Companies has been selected as a ... online information and news publication for resellers of imaging ... year Loffler has earned this prestigious award and the ... Awards honor the best and the brightest in the ... were chosen for their innovative marketing and sales programs, ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 GI for ... before seen reductions in prices of their popular nutritional ... Liposomal Vitamin D3 . Discounts of 40% will ... , GI for Life’s proprietary ColoVite supplement is a ... to promote colon health. One easy-to-take colon vitamin with ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 ISI ... management solutions, has been award the 2014 ... , This award comes as a great honor ... within the Lync ecosystem. Specifically, ISI offers an ... modes of Lync communication, including voice, video, Lync ...
(Date:11/26/2014)... Los Angeles, California (PRWEB) November 26, 2014 ... power score of 3.9 out of 5. This score ... supplies over the three years to 2014 as a ... demand for medical suction machines, which are largely considered ... entering the purchasing process, buyers have some degree of ...
Breaking Medicine News(10 mins):Health News:2014 Best Friday Deals Revealed by Top10InAction 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4
... 19 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider ... from its primary supplier, Atomic Energy of Canada ... of medical isotopes, primarily molybdenum-99 (Mo-99) used in ... advised MDS Nordion that they anticipate the National ...
... 19 First, New York State nonprofit outpatient ... ever-changing Medicaid, Medicaid managed care, Medicare, and insurance ... the healthiest organization. Millin Associates ( ... leader for 27 years, provides expanded services and ...
... Anatomy, Star Chandra Wilson Joins Downy and Quilts for ... Children,s Miracle Network Hospitals throughout the United States CINCINNATI, ... are hospitalized each year in the United States, forced ... away from home in an unfamiliar environment. In ...
... COLUMBIA, Mo. Soldiers and pilots use simulation ... University of Missouri medical, nursing, health professions and ... using medical simulation to train students to recognize ... health professionals. , "Effective training is needed to ...
... Big Ten NetworkUNIVERSITY PARK, Pa., May 19 Neuroscience is ... scans of detainees may not be that far in the ... innovations? Find out by watching the debut of Conversations ... . This new series, hosted by veteran interviewer Patty ...
... of Dental Implants with Laser-Lok(R) Technology over Traditional ... in the dental implant industry, reported today that ... of implants with Laser-Lok (R) surface treatment ... vitro and in animal studies. Laser-Lok implants ...
Cached Medicine News:Health News:MDS Nordion Provides Update on AECL's Medical Isotope Supply Disruption 2Health News:MDS Nordion Provides Update on AECL's Medical Isotope Supply Disruption 3Health News:Nonprofit Outpatient Clinics and Social Service Agencies Outsource Billing to Increase Profits 2Health News:P&G's Downy Fabric Softener Creates the Downy 'Touch of Comfort' Program to Help Provide Quilts to Hospitalized Children 2Health News:P&G's Downy Fabric Softener Creates the Downy 'Touch of Comfort' Program to Help Provide Quilts to Hospitalized Children 3Health News:P&G's Downy Fabric Softener Creates the Downy 'Touch of Comfort' Program to Help Provide Quilts to Hospitalized Children 4Health News:P&G's Downy Fabric Softener Creates the Downy 'Touch of Comfort' Program to Help Provide Quilts to Hospitalized Children 5Health News:Next generation of health care workers train through medical simulation 2Health News:WPSU Debuts New Series; 1st Show Tackles Neuroscience and the Military 2Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 2Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 3
(Date:11/26/2014)... YORK , Nov. 25, 2014  Medtronic,s ... Covidien has been widely discussed in the ... it,s also creating a stronger leading player in ... to Kalorama Information.  The healthcare market research firm ... systems will feature a diverse set of solutions ...
(Date:11/26/2014)... LOVELAND, Colo. , Nov. 25, 2014   Heska ... ; "Heska" or the "Company"), a provider of advanced ... Dr. Robert Grieve , Executive Chair, will attend The ... 11, 2014. The one-on-one conference will be held at The ... IL from 8 a.m. to 2:30 p.m. Please ...
(Date:11/26/2014)... , Nov. 25, 2014  Array BioPharma ... announced that its Chief Executive Officer, ... following upcoming conferences.  The public is welcome ... on the Array BioPharma website:  www.arraybiopharma.com ... 2014Time:1:30 p.m.  Eastern Time Location: Palace Hotel, ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... England, June 1 A leading GP has welcomed the,launch of ... the hope of combating the killer disease. , ... natural supplement,developed by Cambridge scientists, was a huge breakthrough in the ... stroke. , Dozens of research studies have ...
... , Data from Phase II/III Study Presented at Heart ... for Relaxin , SAN MATEO¿ Calif.¿ June 1 ... statistical analyses conducted from Pre-RELAX-AHF, the Phase II portion ... showed that relaxin, the company,s investigational drug for the ...
Cached Medicine Technology:Heart Disease Treatment Breakthrough 2Heart Disease Treatment Breakthrough 3Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables 2Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables 3Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables 4Results and Additional Analyses From Study Show That Corthera's Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables 5
... incorporates advanced technology, which enhances ... in the toughest coronary lesions. ... offered in a 1.5 mm ... 2.0 4.0 mm diameters, ...
Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea...
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
Medicine Products: